Class IIITerminatedD-0870-2023
Drug recall · June 14, 2023
GLYCOPYRROLATE INJECTION recall
Why: Labeling: Label Mix-up
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
- Lots / codes
Lot #: 2205095.1, Exp. Date 7/31/2024
- Quantity
- 9 boxes of 25 vials
- Company
- HF Acquisition Co LLC, Mukilteo, WA
- Distribution
- Distributed in TX, AZ and CA only
- Initiated
- June 6, 2023 · Voluntary: Firm initiated
- Classified
- June 8, 2023
- Reported
- June 14, 2023
- Ended
- February 27, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Glycopyrronium
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.